Overview Financials News + Filings IR Vault Key Docs Charts Transactions Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
Inv. presentation
CC transcript
|
|
REGENERON PHARMACEUTICALS, INC. (REGN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/13/2020 |
8-K
| Investor presentation |
| 01/07/2019 |
8-K
| Investor presentation|
Docs:
|
"Regeneron Provides Update on Commercial and Pipeline Progress at J.P. Morgan Healthcare Conference TARRYTOWN, N.Y. — Regeneron Pharmaceuticals, Inc. will provide a strategic business update to the investor community today at the 37th Annual J.P. Morgan Healthcare Conference. Leonard S. Schleifer, M.D., Ph.D., President and Chief Executive Officer, and George D. Yancopoulos, M.D., Ph.D., President and Chief Scientific Officer, will discuss commercial and pipeline progress across the company's portfolio. Slides and a webcast from the presentation may be accessed from the “Investors & Media” page of Regeneron's website at http://investor.regeneron.com/events.cfm. “Regeneron continues to advance an innovative, homegrown portfolio of marketed and investigational therapies for patients with a ra...",
"Presentation by Leonard S. Schleifer, M.D., Ph.D., President and Chief Executive Officer of Regeneron Pharmaceuticals, Inc., and George D. Yancopoulos, M.D., Ph.D., President and Chief Scientific Officer of Regeneron Pharmaceuticals, Inc., at the 37th Annual J.P. Morgan Healthcare Conference",
"Presentation by Robert E. Landry, Executive Vice President, Finance and Chief Financial Officer of Regeneron Pharmaceuticals, Inc., entitled “2019 Financial Overview.”" |
|
| 01/08/2018 |
8-K
| Investor presentation|
Docs:
|
"Presentation by Leonard S. Schleifer, M.D., Ph.D., President and Chief Executive Officer of Regeneron Pharmaceuticals, Inc., and George D. Yancopoulos, M.D., Ph.D., President and Chief Scientific Officer of Regeneron Pharmaceuticals, Inc., at the 36th Annual J.P. Morgan Healthcare Conference",
"Presentation by Robert E. Landry, Senior Vice President, Finance and Chief Financial Officer of Regeneron Pharmaceuticals, Inc., entitled “2018 Financial Overview.”" |
|
| 01/09/2017 |
8-K
| Investor presentation|
Docs:
|
"Presentation by Leonard S. Schleifer, M.D., Ph.D., President and Chief Executive Officer of Regeneron Pharmaceuticals, Inc., at the 35th Annual J.P. Morgan Healthcare Conference",
"Presentation by Robert E. Landry, Senior Vice President, Finance and Chief Financial Officer of Regeneron Pharmaceuticals, Inc., entitled “2017 Financial Overview.”" |
|
| 01/12/2016 |
8-K
| Form 8-K - Current report |
| 03/16/2015 |
8-K
| Form 8-K - Current report |
| 01/13/2015 |
8-K
| Form 8-K - Current report |
| 03/04/2014 |
8-K
| Form 8-K - Current report |
| 01/14/2014 |
8-K
| Form 8-K - Current report |
| 01/08/2013 |
8-K
| Form 8-K - Current report |
| 01/09/2012 |
8-K
| Form 8-K - Current report |
| 08/22/2011 |
8-K
| Form 8-K - Current report |
|
|